Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000086382', 'term': 'COVID-19'}, {'id': 'D011565', 'term': 'Psoriasis'}], 'ancestors': [{'id': 'D011024', 'term': 'Pneumonia, Viral'}, {'id': 'D011014', 'term': 'Pneumonia'}, {'id': 'D012141', 'term': 'Respiratory Tract Infections'}, {'id': 'D007239', 'term': 'Infections'}, {'id': 'D014777', 'term': 'Virus Diseases'}, {'id': 'D018352', 'term': 'Coronavirus Infections'}, {'id': 'D003333', 'term': 'Coronaviridae Infections'}, {'id': 'D030341', 'term': 'Nidovirales Infections'}, {'id': 'D012327', 'term': 'RNA Virus Infections'}, {'id': 'D008171', 'term': 'Lung Diseases'}, {'id': 'D012140', 'term': 'Respiratory Tract Diseases'}, {'id': 'D017444', 'term': 'Skin Diseases, Papulosquamous'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'RETROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 2500}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2023-03-15', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-07', 'completionDateStruct': {'date': '2023-07-30', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2023-07-26', 'studyFirstSubmitDate': '2023-07-25', 'studyFirstSubmitQcDate': '2023-07-25', 'lastUpdatePostDateStruct': {'date': '2023-08-01', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-07-27', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2023-05-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'The recurrence/exacerbation of psoriasis following SARS-CoV-2 infection', 'timeFrame': 'March 15,2023 to May 30,2023', 'description': 'The impact of SARS-CoV-2 infection on psoriasis in patients receiving different baseline therapies of psoriasis.'}], 'secondaryOutcomes': [{'measure': 'Univariate and multivariate analyses identify risk factors with psoriasis exacerbation/recurrence after SARS-CoV-2 infection', 'timeFrame': 'March 15,2023 to May 30,2023', 'description': 'Univariate and multivariate analyses identify risk factors with psoriasis exacerbation/recurrence after SARS-CoV-2 infection'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['psoriasis', 'covid-19'], 'conditions': ['Psoriasis Patients', 'COVID-19']}, 'referencesModule': {'references': [{'pmid': '38710539', 'type': 'DERIVED', 'citation': 'Liu Y, Xu Z, Zhou J, Chen A, Zhang J, Kang X, Jiang X, Lyu C, Shi C, Shi Y, Liu X, Li F, Yang B, Huang Y, Yu C, Wang G. Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China. Chin Med J (Engl). 2024 Jul 20;137(14):1736-1743. doi: 10.1097/CM9.0000000000003024. Epub 2024 May 6.'}]}, 'descriptionModule': {'briefSummary': 'A retrospective analysis based on database was conducted to evaluate the correlation between covid-19 infection and the condition and treatment of psoriasis patients.', 'detailedDescription': 'Based on the patients registered in the psoriasis patient database of each center, the patients were followed up by telephone, and the severity of covid-19 infection, the change of psoriasis condition and the adjustment of treatment methods of psoriasis patients were collected for retrospective analysis.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Psoriasis patients registered in the database from January 2018 to November 2022', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion criteria ----\n\n1. No age limit, both male and female are accepted;\n2. Psoriasis patients registered in the database;\n3. Patients or their families can cooperate to complete the follow-up information survey (questionnaire, telephone, etc.) independently, and ensure the authenticity of the data provided.\n\nExclusion criteria ----\n\nPatients are thought having conditions which are not appropriated for attending this clinical trial.'}, 'identificationModule': {'nctId': 'NCT05961605', 'briefTitle': 'COVID-19 Associated With Psoriasis', 'organization': {'class': 'OTHER', 'fullName': 'Xijing Hospital'}, 'officialTitle': 'Retrospective Clinical Study of COVID-19 Associated With the Condition and Treatment of Patients With Chinese Psoriasis', 'orgStudyIdInfo': {'id': 'XJPF202303-PSO&COVID-19'}}, 'contactsLocationsModule': {'locations': [{'zip': '400016', 'city': 'Chongqing', 'state': 'Chongqing Municipality', 'status': 'COMPLETED', 'country': 'China', 'facility': 'The First Affiliated Hospital of Chongqing Medical University', 'geoPoint': {'lat': 29.56026, 'lon': 106.55771}}, {'zip': '730000', 'city': 'Lanzhou', 'state': 'Gansu', 'status': 'COMPLETED', 'country': 'China', 'facility': 'The First Hospital of Lanzhou University', 'geoPoint': {'lat': 36.05701, 'lon': 103.83987}}, {'zip': '510091', 'city': 'Guangzhou', 'state': 'Guangdong', 'status': 'COMPLETED', 'country': 'China', 'facility': 'Dermatology Hospital of Southern Medical University', 'geoPoint': {'lat': 23.11667, 'lon': 113.25}}, {'zip': '130041', 'city': 'Changchun', 'state': 'Jilin', 'status': 'COMPLETED', 'country': 'China', 'facility': 'The Second Hospital of Jilin University', 'geoPoint': {'lat': 43.88, 'lon': 125.32278}}, {'zip': '116021', 'city': 'Dalian', 'state': 'Liaoning', 'status': 'COMPLETED', 'country': 'China', 'facility': 'Dalian Dermatosis Hospital', 'geoPoint': {'lat': 38.91222, 'lon': 121.60222}}, {'zip': '810000', 'city': 'Xining', 'state': 'Qinghai', 'status': 'COMPLETED', 'country': 'China', 'facility': "Xining First People's Hospital", 'geoPoint': {'lat': 36.62554, 'lon': 101.75739}}, {'zip': '710032', 'city': "Xi'an", 'state': 'Shaanxi', 'status': 'RECRUITING', 'country': 'China', 'contacts': [{'name': 'CHEN YU', 'role': 'CONTACT'}], 'facility': 'Xijing Hospital, The Fourth Military Medical University', 'geoPoint': {'lat': 34.25833, 'lon': 108.92861}}, {'zip': '200443', 'city': 'Shanghai', 'state': 'Shanghai Municipality', 'status': 'COMPLETED', 'country': 'China', 'facility': 'Shanghai Skin Disease Hospital, Tongji University School of Medicine', 'geoPoint': {'lat': 31.22222, 'lon': 121.45806}}, {'zip': '518053', 'city': 'Shenzhen', 'state': 'Shenzhen', 'status': 'COMPLETED', 'country': 'China', 'facility': 'The University of Hong Kong-Shenzhen Hospital', 'geoPoint': {'lat': 22.54554, 'lon': 114.0683}}, {'zip': '610041', 'city': 'Chengdu', 'state': 'Sichuan', 'status': 'COMPLETED', 'country': 'China', 'facility': 'West China Hospital, Sichuan University', 'geoPoint': {'lat': 30.66667, 'lon': 104.06667}}, {'zip': '300021', 'city': 'Tianjin', 'state': 'Tianjin Municipality', 'status': 'COMPLETED', 'country': 'China', 'facility': 'Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital', 'geoPoint': {'lat': 39.14222, 'lon': 117.17667}}, {'zip': '830001', 'city': 'Ürümqi', 'state': 'Xinjiang', 'status': 'COMPLETED', 'country': 'China', 'facility': "People's Hospital of Xinjiang Uygur Autonomous Region,Xinjiang Key Laboratory of Dermatology Research", 'geoPoint': {'lat': 43.80096, 'lon': 87.60046}}], 'centralContacts': [{'name': 'GANG WANG, M.D.', 'role': 'CONTACT', 'email': 'xjwgang@fmmu.edu.cn', 'phone': '13571991903'}, {'name': 'CHEN YU', 'role': 'CONTACT', 'phone': '13571991903'}], 'overallOfficials': [{'name': 'GANG WANG, M.D.', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Xijing Hospital, The Fourth Military Medical University'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Gang Wang, MD', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR_INVESTIGATOR', 'investigatorTitle': 'Chief Director of Department of Dermatology', 'investigatorFullName': 'Gang Wang, MD', 'investigatorAffiliation': 'Xijing Hospital'}}}}